Comparison of the Value of PET/CT and Multimodal MRI in the Differential Diagnosis of Glioma Recurrence and Radiation Brain Injury
1.Yinzhou Hospital Affiliated to Medical School of Ningbo University,Ningbo 315040,China
2.Zhejiang University Mingzhou Hospital,Ningbo 315040,China
*Corresponding author:CHEN Mengda,Associate chief physician;E-mail:chenmengda0000@163.com
CHEN Mengda,LI Qiang,WANG Youliang, et al. Comparison of the Value of PET/CT and Multimodal MRI in the Differential Diagnosis of Glioma Recurrence and Radiation Brain Injury [J]. Chinese General Practice, 2019, 22(11): 1312-1318. DOI: 10.12114/j.issn.1007-9572.2018.00.451.
陈孟达,李强,王友良等. 正电子发射计算机断层显像与多模态磁共振成像鉴别脑胶质瘤术后肿瘤复发与放射性脑损伤的价值研究[J]. 中国全科医学, 2019, 22(11): 1312-1318. DOI: 10.12114/j.issn.1007-9572.2018.00.451.
[1]SAITO N,AOKI K,HIRAI N,et al.Effect of Notch expression in glioma stem cells on therapeutic response to chemo-radiotherapy in recurrent glioblastoma[J].Brain Tumor Pathology,2015,32(3):176-183.DOI:10.1007/s10014-015-0215-7.
[2]KHAZAEE A,EBRAHIMZADEH A,BABAJANI-FEREMI A.Identifying patients with Alzheimer's disease using resting-state fMRI and graph theory[J].Clin Neurophysiol,2015,126(11):2132-2141.DOI:10.1016/j.clinph.2015.02.060.
[3]XIE S,XIAO J,DUAN H,et al.Quantitative measurement of oxygen extraction fraction by MRI in patients with cerebrovascular disease:pre- and post-surgery[J].Turk Neurosurg,2015,25(1):21-28.DOI:10.5137/1019-5149.JTN.8987-13.1.
[4]ZHAN J,GAO L,ZHOU F,et al.Decreased regional homogeneity in patients with acute mild traumatic brain injury:a resting-state fMRI study[J].J Nerv Ment Dis,2015,203(10):786-791.DOI:10.1097/NMD.0000000000000368.
[5]CAMMAROTO G,QUARTUCCIO N,SINDONI A,et al.The role of PET/CT in the management of patients affected by head and neck tumors:a review of the literature[J].Eur Arch Otorhinolaryngol,2016,273(8):1961-1973.DOI:10.1007/s00405-015-3651-4.
[6]杜伟,庞长河,薛亚轲,等.2014年ESMO《高级别胶质瘤诊断、治疗与随访指南》解读[J].中华神经医学杂志,2015,14(3):217-220.DOI:10.3760/cma.j.issn.1671-8925.2015.03.001.
DU W,PANG C H,XUE Y K,et al.Guidelines of diagnosis,treatment and follow-up of high-grade gliomas by European Society for Medical Oncology in 2014:an interpretation[J].Chinese Journal of Neuromedicine,2015,14(3):217-220.DOI:10.3760/cma.j.issn.1671-8925.2015.03.001.
[7]JOHANSEN C,SCHUZ J,ANDREASEN A S,et al.Study designs may influence results:the problems with questionnaire-based case-control studies on the epidemiology of glioma[J].Br J Cancer,2017,116(7):841-848.DOI:10.1038/bjc.2017.46.
[8]MA H,WANG Z,XU K,et al.Three-dimensional arterial spin labeling imaging and dynamic susceptibility contrast perfusion-weighted imaging value in diagnosing glioma grade prior to surgery[J].Exp Ther Med,2017,13(6):2691-2698.DOI:10.3892/etm.2017.4370.
[9]冯辛格.PWI鉴别脑胶质瘤复发与放射性脑损伤的临床价值分析[J].中国CT和MRI杂志,2017,15(8):40-42.DOI:10.3969/j.issn.1672-5131.2017.08.012.
FENG X G.Analysis of the changes of PWI rCBV and rCBF ratio in the diagnosis of recurrence of glioma[J].Chinese Journal of CT and MRI,2017,15(8):40-42.DOI:10.3969/j.issn.1672-5131.2017.08.012.
[10]杨宇,黄艳芳,周智慧,等.放射性脑损伤的MRI及灌注成像分析[J].中国CT和MRI杂志,2016,14(6):1-2,12.DOI:10.3969/j.issn.1672-5131.2016.06.001.
YANG Y,HUANG Y F,ZHOU Z H,et al.MRI and perfusion imaging analysis of radiation-induced brain injury[J].Chinese Journal of CT and MRI,2016,14(6):1-2,12.DOI:10.3969/j.issn.1672-5131.2016.06.001.
[11]WANG Q,ZHANG H,ZHANG J,et al.The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas:a systematic review and meta-analysis[J].Eur Radiol,2016,26(8):2670-2684.DOI:10.1007/s00330-015-4046-z.
[12]TONG T,YANG Z,CHEN J W,et al.Dynamic 1H-MRS assessment of brain tumors:a novel approach for differential diagnosis of glioma[J].Oncotarget,2015,6(31):32257-32265.DOI:10.18632/oncotarget.4899.
[13]DI COSTANZO A,SCARABINO T,TROISI F,et al.Recurrent glioblastoma multiforme versus radiation injury:a multiparametric 3-T MR approach[J].Radiol Med,2014,119(8):616-624.DOI:10.1007/s11547-013-0371-y.
[14]MARTINEZ-AMADOR N,JIMENEZ-BONILLA J,MARTINEZ-RODRIQUEZ I,et al.Value of the visual and semiquantitative analysis of carbon-11-methionine PET/CT in brain tumors' recurrence versus post-therapeutic changes[J].Nucl Med Commun,2017,38(12):1125-1132.DOI:10.1097/MNM.0000000000000754.
[15]D'SOUZA M M,SHARMA R,JAIMINI A,et al.11C-MET PET/CT and advanced MRI in the evaluation of tumor recurrence in high-grade gliomas[J].Clin Nucl Med,2014,39(9):791-798.DOI:10.1097/RLU.0000000000000532.